Finch grabs a $53M round designed to take their ‘breakthrough’ microbiome treatment through a potentially pivotal trial
With a breakthrough designation in one hand and a fresh $53 million in venture backing in the other, Somerville, MA-based Finch Therapeutics is taking a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.